ID   SO1B1_HUMAN             Reviewed;         691 AA.
AC   Q9Y6L6; B2R7G2; Q29R64; Q9NQ37; Q9UBF3; Q9UH89;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2000, sequence version 2.
DT   10-MAY-2017, entry version 157.
DE   RecName: Full=Solute carrier organic anion transporter family member 1B1;
DE   AltName: Full=Liver-specific organic anion transporter 1;
DE            Short=LST-1;
DE   AltName: Full=OATP-C;
DE   AltName: Full=Sodium-independent organic anion-transporting polypeptide 2;
DE            Short=OATP-2;
DE   AltName: Full=Solute carrier family 21 member 6;
GN   Name=SLCO1B1; Synonyms=LST1, OATP1B1, OATP2, OATPC, SLC21A6;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, AND VARIANTS
RP   LYS-152 AND ASN-241.
RC   TISSUE=Liver;
RX   PubMed=10358072; DOI=10.1074/jbc.274.24.17159;
RA   Abe T., Kakyo M., Tokui T., Nakagomi R., Nishio T., Nakai D.,
RA   Nomura H., Unno M., Suzuki M., Naitoh T., Matsuno S., Yawo H.;
RT   "Identification of a novel gene family encoding human liver-specific
RT   organic anion transporter LST-1.";
RL   J. Biol. Chem. 274:17159-17163(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, AND VARIANT
RP   ASP-130.
RC   TISSUE=Liver;
RX   PubMed=10601278; DOI=10.1074/jbc.274.52.37161;
RA   Hsiang B.H., Zhu Y., Wang Z., Wu Y., Sasseville V., Yang W.-P.,
RA   Kirchgessner T.G.;
RT   "A novel human hepatic organic anion transporting polypeptide (OATP2).
RT   Identification of a liver-specific human organic anion transporting
RT   polypeptide and identification of rat and human hydroxymethylglutaryl-
RT   CoA reductase inhibitor transporters.";
RL   J. Biol. Chem. 274:37161-37168(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=10644574;
RA   Koenig J., Cui Y., Nies A.T., Keppler D.;
RT   "A novel human organic anion transporting polypeptide localized to the
RT   basolateral hepatocyte membrane.";
RL   Am. J. Physiol. 278:G156-G164(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RA   Nezu J.;
RL   Submitted (APR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10779507; DOI=10.1074/jbc.M001448200;
RA   Koenig J., Cui Y., Nies A.T., Keppler D.;
RT   "Localization and genomic organization of a new hepatocellular organic
RT   anion transporting polypeptide.";
RL   J. Biol. Chem. 275:23161-23168(2000).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ASP-130.
RG   SeattleSNPs variation discovery resource;
RL   Submitted (FEB-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Mammary gland;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANTS ASP-130 AND
RP   THR-155.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   FUNCTION, TISSUE SPECIFICITY, AND INVOLVEMENT IN HBLRR.
RX   PubMed=22232210; DOI=10.1172/JCI59526;
RA   van de Steeg E., Stranecky V., Hartmannova H., Noskova L.,
RA   Hrebicek M., Wagenaar E., van Esch A., de Waart D.R.,
RA   Oude Elferink R.P., Kenworthy K.E., Sticova E., al-Edreesi M.,
RA   Knisely A.S., Kmoch S., Jirsa M., Schinkel A.H.;
RT   "Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome
RT   by interrupting conjugated bilirubin reuptake into the liver.";
RL   J. Clin. Invest. 122:519-528(2012).
RN   [11]
RP   GLYCOSYLATION AT ASN-134; ASN-503 AND ASN-516.
RX   PubMed=23285087; DOI=10.1371/journal.pone.0052563;
RA   Yao J., Hong W., Huang J., Zhan K., Huang H., Hong M.;
RT   "N-Glycosylation dictates proper processing of organic anion
RT   transporting polypeptide 1B1.";
RL   PLoS ONE 7:E52563-E52563(2012).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-293; SER-295; SER-672
RP   AND SER-682, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   VARIANTS LEU-73; ALA-82; ASP-130; LYS-152; THR-155; GLY-156; ALA-174;
RP   ASN-241; THR-353; ASP-432; GLY-462; ALA-488; GLY-655 AND GLY-667, AND
RP   CHARACTERIZATION.
RX   PubMed=11477075; DOI=10.1074/jbc.M103792200;
RA   Tirona R.G., Leake B.F., Merino G., Kim R.B.;
RT   "Polymorphisms in OATP-C: identification of multiple allelic variants
RT   associated with altered transport activity among European- and
RT   African-Americans.";
RL   J. Biol. Chem. 276:35669-35675(2001).
RN   [14]
RP   CHARACTERIZATION OF VARIANTS ASP-130; THR-155 AND ARG-193, FUNCTION,
RP   AND SUBCELLULAR LOCATION.
RX   PubMed=12196548; DOI=10.1074/jbc.M207735200;
RA   Michalski C., Cui Y., Nies A.T., Nuessler A.K., Neuhaus P.,
RA   Zanger U.M., Klein K., Eichelbaum M., Keppler D., Koenig J.;
RT   "A naturally occurring mutation in the SLC21A6 gene causing impaired
RT   membrane localization of the hepatocyte uptake transporter.";
RL   J. Biol. Chem. 277:43058-43063(2002).
RN   [15]
RP   VARIANTS ASP-130; LYS-152; ALA-174 AND ASN-241.
RX   PubMed=12130747; DOI=10.1124/jpet.302.2.804;
RA   Nozawa T., Nakajima M., Tamai I., Noda K., Nezu J., Sai Y., Tsuji A.,
RA   Yokoi T.;
RT   "Genetic polymorphisms of human organic anion transporters OATP-C
RT   (SLC21A6) and OATP-B (SLC21A9): allele frequencies in the Japanese
RT   population and functional analysis.";
RL   J. Pharmacol. Exp. Ther. 302:804-813(2002).
CC   -!- FUNCTION: Mediates the Na(+)-independent uptake of organic anions
CC       such as pravastatin, taurocholate, methotrexate,
CC       dehydroepiandrosterone sulfate, 17-beta-glucuronosyl estradiol,
CC       estrone sulfate, prostaglandin E2, thromboxane B2, leukotriene C3,
CC       leukotriene E4, thyroxine and triiodothyronine. Involved in the
CC       clearance of bile acids and organic anions from the liver.
CC       {ECO:0000269|PubMed:10358072, ECO:0000269|PubMed:10601278,
CC       ECO:0000269|PubMed:12196548, ECO:0000269|PubMed:22232210}.
CC   -!- SUBCELLULAR LOCATION: Basolateral cell membrane
CC       {ECO:0000269|PubMed:12196548}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:12196548}. Note=Detected in basolateral
CC       membranes of hepatocytes.
CC   -!- TISSUE SPECIFICITY: Highly expressed in liver, at the basolateral
CC       membranes of centrilobular hepatocytes. Not detected in heart,
CC       brain, placenta, lung, skeletal muscle, kidney, pancreas, spleen,
CC       thymus, prostate, testis, ovary, small intestine, colon and
CC       leukocyte. {ECO:0000269|PubMed:10358072,
CC       ECO:0000269|PubMed:10601278, ECO:0000269|PubMed:22232210}.
CC   -!- DISEASE: Hyperbilirubinemia, Rotor type (HBLRR) [MIM:237450]: An
CC       autosomal recessive form of primary conjugated hyperbilirubinemia.
CC       Affected individuals develop mild jaundice not associated with
CC       hemolysis shortly after birth or in childhood. They have delayed
CC       plasma clearance of the unconjugated anionic dye bromsulphthalein
CC       and prominent urinary excretion of coproporphyrin I. Hepatic
CC       pigmentation is normal. {ECO:0000269|PubMed:22232210}. Note=The
CC       disease is caused by mutations affecting the gene represented in
CC       this entry.
CC   -!- SIMILARITY: Belongs to the organo anion transporter (TC 2.A.60)
CC       family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/slco1b1/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF060500; AAD38323.1; -; mRNA.
DR   EMBL; AF205071; AAF20212.1; -; mRNA.
DR   EMBL; AJ132573; CAB62577.1; -; mRNA.
DR   EMBL; AB026257; BAA78639.1; -; mRNA.
DR   EMBL; AJ400749; CAB97007.1; -; Genomic_DNA.
DR   EMBL; AJ400750; CAB97007.1; JOINED; Genomic_DNA.
DR   EMBL; AJ400751; CAB97007.1; JOINED; Genomic_DNA.
DR   EMBL; AJ400752; CAB97007.1; JOINED; Genomic_DNA.
DR   EMBL; AJ400753; CAB97007.1; JOINED; Genomic_DNA.
DR   EMBL; AJ400754; CAB97007.1; JOINED; Genomic_DNA.
DR   EMBL; AJ400755; CAB97007.1; JOINED; Genomic_DNA.
DR   EMBL; AJ400756; CAB97007.1; JOINED; Genomic_DNA.
DR   EMBL; AJ400757; CAB97007.1; JOINED; Genomic_DNA.
DR   EMBL; AJ400758; CAB97007.1; JOINED; Genomic_DNA.
DR   EMBL; AJ400759; CAB97007.1; JOINED; Genomic_DNA.
DR   EMBL; AJ400760; CAB97007.1; JOINED; Genomic_DNA.
DR   EMBL; AJ400761; CAB97007.1; JOINED; Genomic_DNA.
DR   EMBL; AJ400762; CAB97007.1; JOINED; Genomic_DNA.
DR   EMBL; AY945934; AAX20114.1; -; Genomic_DNA.
DR   EMBL; AK312970; BAG35809.1; -; mRNA.
DR   EMBL; CH471094; EAW96420.1; -; Genomic_DNA.
DR   EMBL; BC114376; AAI14377.1; -; mRNA.
DR   CCDS; CCDS8685.1; -.
DR   RefSeq; NP_006437.3; NM_006446.4.
DR   UniGene; Hs.449738; -.
DR   ProteinModelPortal; Q9Y6L6; -.
DR   BioGrid; 115847; 9.
DR   STRING; 9606.ENSP00000256958; -.
DR   BindingDB; Q9Y6L6; -.
DR   ChEMBL; CHEMBL1697668; -.
DR   DrugBank; DB06151; Acetylcysteine.
DR   DrugBank; DB06403; Ambrisentan.
DR   DrugBank; DB00345; Aminohippuric acid.
DR   DrugBank; DB01076; Atorvastatin.
DR   DrugBank; DB06626; Axitinib.
DR   DrugBank; DB01053; Benzylpenicillin.
DR   DrugBank; DB01393; Bezafibrate.
DR   DrugBank; DB06772; Cabazitaxel.
DR   DrugBank; DB00520; Caspofungin.
DR   DrugBank; DB00439; Cerivastatin.
DR   DrugBank; DB02659; Cholic Acid.
DR   DrugBank; DB01211; Clarithromycin.
DR   DrugBank; DB05239; Cobimetinib.
DR   DrugBank; DB00286; Conjugated Equine Estrogens.
DR   DrugBank; DB00091; Cyclosporine.
DR   DrugBank; DB08912; Dabrafenib.
DR   DrugBank; DB09102; Daclatasvir.
DR   DrugBank; DB05804; dehydroepiandrosterone sulfate.
DR   DrugBank; DB00509; Dextrothyroxine.
DR   DrugBank; DB00390; Digoxin.
DR   DrugBank; DB00917; Dinoprostone.
DR   DrugBank; DB04881; Elacridar.
DR   DrugBank; DB06210; Eltrombopag.
DR   DrugBank; DB09272; Eluxadoline.
DR   DrugBank; DB00783; Estradiol.
DR   DrugBank; DB00655; Estrone.
DR   DrugBank; DB00973; Ezetimibe.
DR   DrugBank; DB00950; Fexofenadine.
DR   DrugBank; DB01095; Fluvastatin.
DR   DrugBank; DB08884; Gadoxetic acid.
DR   DrugBank; DB01241; Gemfibrozil.
DR   DrugBank; DB11575; Grazoprevir.
DR   DrugBank; DB01892; Hyperforin.
DR   DrugBank; DB09054; Idelalisib.
DR   DrugBank; DB00224; Indinavir.
DR   DrugBank; DB00762; Irinotecan.
DR   DrugBank; DB00583; L-Carnitine.
DR   DrugBank; DB00451; Levothyroxine.
DR   DrugBank; DB00279; Liothyronine.
DR   DrugBank; DB01583; Liotrix.
DR   DrugBank; DB00227; Lovastatin.
DR   DrugBank; DB00563; Methotrexate.
DR   DrugBank; DB00688; Mycophenolate mofetil.
DR   DrugBank; DB02691; N-Cholylglycine.
DR   DrugBank; DB00220; Nelfinavir.
DR   DrugBank; DB00275; Olmesartan.
DR   DrugBank; DB01092; Ouabain.
DR   DrugBank; DB00213; Pantoprazole.
DR   DrugBank; DB06589; Pazopanib.
DR   DrugBank; DB00859; Penicillamine.
DR   DrugBank; DB01132; Pioglitazone.
DR   DrugBank; DB08860; Pitavastatin.
DR   DrugBank; DB00175; Pravastatin.
DR   DrugBank; DB00908; Quinidine.
DR   DrugBank; DB00912; Repaglinide.
DR   DrugBank; DB01045; Rifampicin.
DR   DrugBank; DB08864; Rilpivirine.
DR   DrugBank; DB00503; Ritonavir.
DR   DrugBank; DB00412; Rosiglitazone.
DR   DrugBank; DB01098; Rosuvastatin.
DR   DrugBank; DB09292; Sacubitril.
DR   DrugBank; DB01232; Saquinavir.
DR   DrugBank; DB11362; Selexipag.
DR   DrugBank; DB06290; Simeprevir.
DR   DrugBank; DB00641; Simvastatin.
DR   DrugBank; DB00877; Sirolimus.
DR   DrugBank; DB00669; Sumatriptan.
DR   DrugBank; DB04348; Taurocholic Acid.
DR   DrugBank; DB09137; Technetium Tc 99m Mebrofenin.
DR   DrugBank; DB00197; Troglitazone.
DR   DrugBank; DB00177; Valsartan.
DR   DrugBank; DB00661; Verapamil.
DR   GuidetoPHARMACOLOGY; 1220; -.
DR   TCDB; 2.A.60.1.5; the organo anion transporter (oat) family.
DR   iPTMnet; Q9Y6L6; -.
DR   PhosphoSitePlus; Q9Y6L6; -.
DR   BioMuta; SLCO1B1; -.
DR   DMDM; 12643959; -.
DR   EPD; Q9Y6L6; -.
DR   PaxDb; Q9Y6L6; -.
DR   PeptideAtlas; Q9Y6L6; -.
DR   PRIDE; Q9Y6L6; -.
DR   Ensembl; ENST00000256958; ENSP00000256958; ENSG00000134538.
DR   GeneID; 10599; -.
DR   KEGG; hsa:10599; -.
DR   UCSC; uc001req.5; human.
DR   CTD; 10599; -.
DR   DisGeNET; 10599; -.
DR   GeneCards; SLCO1B1; -.
DR   GeneReviews; SLCO1B1; -.
DR   HGNC; HGNC:10959; SLCO1B1.
DR   HPA; HPA050892; -.
DR   MalaCards; SLCO1B1; -.
DR   MIM; 237450; phenotype.
DR   MIM; 604843; gene.
DR   neXtProt; NX_Q9Y6L6; -.
DR   OpenTargets; ENSG00000134538; -.
DR   Orphanet; 3111; Rotor syndrome.
DR   Orphanet; 413696; Statin toxicity.
DR   PharmGKB; PA134865839; -.
DR   eggNOG; KOG3626; Eukaryota.
DR   eggNOG; ENOG410XRSF; LUCA.
DR   GeneTree; ENSGT00760000119014; -.
DR   HOGENOM; HOG000231269; -.
DR   HOVERGEN; HBG063896; -.
DR   InParanoid; Q9Y6L6; -.
DR   KO; K05043; -.
DR   OMA; IIHIERR; -.
DR   OrthoDB; EOG091G08QD; -.
DR   PhylomeDB; Q9Y6L6; -.
DR   TreeFam; TF317540; -.
DR   Reactome; R-HSA-159418; Recycling of bile acids and salts.
DR   Reactome; R-HSA-879518; Transport of organic anions.
DR   ChiTaRS; SLCO1B1; human.
DR   GeneWiki; SLCO1B1; -.
DR   GenomeRNAi; 10599; -.
DR   PRO; PR:Q9Y6L6; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000134538; -.
DR   CleanEx; HS_LST1; -.
DR   CleanEx; HS_SLCO1B1; -.
DR   ExpressionAtlas; Q9Y6L6; baseline and differential.
DR   Genevisible; Q9Y6L6; HS.
DR   GO; GO:0016323; C:basolateral plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0016020; C:membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0015125; F:bile acid transmembrane transporter activity; TAS:Reactome.
DR   GO; GO:0015347; F:sodium-independent organic anion transmembrane transporter activity; TAS:ProtInc.
DR   GO; GO:0015349; F:thyroid hormone transmembrane transporter activity; TAS:Reactome.
DR   GO; GO:0015721; P:bile acid and bile salt transport; TAS:Reactome.
DR   GO; GO:0015711; P:organic anion transport; TAS:ProtInc.
DR   GO; GO:0043252; P:sodium-independent organic anion transport; TAS:Reactome.
DR   CDD; cd06174; MFS; 1.
DR   InterPro; IPR002350; Kazal_dom.
DR   InterPro; IPR020846; MFS_dom.
DR   InterPro; IPR004156; OA_transporter.
DR   PANTHER; PTHR11388; PTHR11388; 1.
DR   Pfam; PF07648; Kazal_2; 1.
DR   Pfam; PF03137; OATP; 1.
DR   SUPFAM; SSF100895; SSF100895; 1.
DR   SUPFAM; SSF103473; SSF103473; 3.
DR   TIGRFAMs; TIGR00805; oat; 1.
DR   PROSITE; PS51465; KAZAL_2; 1.
DR   PROSITE; PS50850; MFS; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Complete proteome; Disulfide bond; Glycoprotein;
KW   Ion transport; Membrane; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    691       Solute carrier organic anion transporter
FT                                family member 1B1.
FT                                /FTId=PRO_0000191050.
FT   TOPO_DOM      1     28       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     29     48       Helical; Name=1. {ECO:0000255}.
FT   TOPO_DOM     49     67       Extracellular. {ECO:0000255}.
FT   TRANSMEM     68     88       Helical; Name=2. {ECO:0000255}.
FT   TOPO_DOM     89     94       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     95    119       Helical; Name=3. {ECO:0000255}.
FT   TOPO_DOM    120    168       Extracellular. {ECO:0000255}.
FT   TRANSMEM    169    197       Helical; Name=4. {ECO:0000255}.
FT   TOPO_DOM    198    216       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    217    237       Helical; Name=5. {ECO:0000255}.
FT   TOPO_DOM    238    255       Extracellular. {ECO:0000255}.
FT   TRANSMEM    256    280       Helical; Name=6. {ECO:0000255}.
FT   TOPO_DOM    281    331       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    332    353       Helical; Name=7. {ECO:0000255}.
FT   TOPO_DOM    354    373       Extracellular. {ECO:0000255}.
FT   TRANSMEM    374    397       Helical; Name=8. {ECO:0000255}.
FT   TOPO_DOM    398    401       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    402    425       Helical; Name=9. {ECO:0000255}.
FT   TOPO_DOM    426    537       Extracellular. {ECO:0000255}.
FT   TRANSMEM    538    560       Helical; Name=10. {ECO:0000255}.
FT   TOPO_DOM    561    569       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    570    595       Helical; Name=11. {ECO:0000255}.
FT   TOPO_DOM    596    629       Extracellular. {ECO:0000255}.
FT   TRANSMEM    630    647       Helical; Name=12. {ECO:0000255}.
FT   TOPO_DOM    648    691       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN      453    508       Kazal-like. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00798}.
FT   MOD_RES     293    293       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     295    295       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     672    672       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     682    682       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   CARBOHYD    130    130       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    134    134       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:23285087}.
FT   CARBOHYD    432    432       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD    503    503       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:23285087}.
FT   CARBOHYD    516    516       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:23285087}.
FT   CARBOHYD    617    617       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   DISULFID    459    485       {ECO:0000255|PROSITE-ProRule:PRU00798}.
FT   DISULFID    463    474       {ECO:0000255|PROSITE-ProRule:PRU00798}.
FT   DISULFID    465    489       {ECO:0000255|PROSITE-ProRule:PRU00798}.
FT   VARIANT      73     73       F -> L (in dbSNP:rs56101265).
FT                                {ECO:0000269|PubMed:11477075}.
FT                                /FTId=VAR_015070.
FT   VARIANT      82     82       V -> A (in dbSNP:rs56061388).
FT                                {ECO:0000269|PubMed:11477075}.
FT                                /FTId=VAR_015071.
FT   VARIANT     130    130       N -> D (in dbSNP:rs2306283).
FT                                {ECO:0000269|PubMed:10601278,
FT                                ECO:0000269|PubMed:11477075,
FT                                ECO:0000269|PubMed:12130747,
FT                                ECO:0000269|PubMed:12196548,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|Ref.6}.
FT                                /FTId=VAR_015072.
FT   VARIANT     151    151       N -> S (in dbSNP:rs2306282).
FT                                /FTId=VAR_057724.
FT   VARIANT     152    152       R -> K. {ECO:0000269|PubMed:10358072,
FT                                ECO:0000269|PubMed:11477075,
FT                                ECO:0000269|PubMed:12130747}.
FT                                /FTId=VAR_015073.
FT   VARIANT     155    155       P -> T (decreased transport activity;
FT                                dbSNP:rs11045819).
FT                                {ECO:0000269|PubMed:11477075,
FT                                ECO:0000269|PubMed:12196548,
FT                                ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_015074.
FT   VARIANT     156    156       E -> G (decreased transport activity;
FT                                dbSNP:rs72559745).
FT                                {ECO:0000269|PubMed:11477075}.
FT                                /FTId=VAR_015075.
FT   VARIANT     174    174       V -> A (decreased transport activity;
FT                                dbSNP:rs4149056).
FT                                {ECO:0000269|PubMed:11477075,
FT                                ECO:0000269|PubMed:12130747}.
FT                                /FTId=VAR_015076.
FT   VARIANT     193    193       L -> R (strongly decreases expression at
FT                                the plasma membrane; abolishes transport
FT                                activity; dbSNP:rs72559746).
FT                                {ECO:0000269|PubMed:12196548}.
FT                                /FTId=VAR_015077.
FT   VARIANT     241    241       D -> N. {ECO:0000269|PubMed:10358072,
FT                                ECO:0000269|PubMed:11477075,
FT                                ECO:0000269|PubMed:12130747}.
FT                                /FTId=VAR_015078.
FT   VARIANT     245    245       I -> V (in dbSNP:rs11045852).
FT                                /FTId=VAR_060108.
FT   VARIANT     353    353       I -> T (in dbSNP:rs55901008).
FT                                {ECO:0000269|PubMed:11477075}.
FT                                /FTId=VAR_015079.
FT   VARIANT     432    432       N -> D (in dbSNP:rs56387224).
FT                                {ECO:0000269|PubMed:11477075}.
FT                                /FTId=VAR_015080.
FT   VARIANT     462    462       D -> G (in dbSNP:rs72559748).
FT                                {ECO:0000269|PubMed:11477075}.
FT                                /FTId=VAR_015081.
FT   VARIANT     488    488       G -> A (in dbSNP:rs59502379).
FT                                {ECO:0000269|PubMed:11477075}.
FT                                /FTId=VAR_015082.
FT   VARIANT     643    643       L -> F (in dbSNP:rs34671512).
FT                                /FTId=VAR_057725.
FT   VARIANT     655    655       D -> G (in dbSNP:rs56199088).
FT                                {ECO:0000269|PubMed:11477075}.
FT                                /FTId=VAR_015083.
FT   VARIANT     667    667       E -> G (in dbSNP:rs55737008).
FT                                {ECO:0000269|PubMed:11477075}.
FT                                /FTId=VAR_015084.
SQ   SEQUENCE   691 AA;  76449 MW;  D13D5130189383A3 CRC64;
     MDQNQHLNKT AEAQPSENKK TRYCNGLKMF LAALSLSFIA KTLGAIIMKS SIIHIERRFE
     ISSSLVGFID GSFEIGNLLV IVFVSYFGSK LHRPKLIGIG CFIMGIGGVL TALPHFFMGY
     YRYSKETNIN SSENSTSTLS TCLINQILSL NRASPEIVGK GCLKESGSYM WIYVFMGNML
     RGIGETPIVP LGLSYIDDFA KEGHSSLYLG ILNAIAMIGP IIGFTLGSLF SKMYVDIGYV
     DLSTIRITPT DSRWVGAWWL NFLVSGLFSI ISSIPFFFLP QTPNKPQKER KASLSLHVLE
     TNDEKDQTAN LTNQGKNITK NVTGFFQSFK SILTNPLYVM FVLLTLLQVS SYIGAFTYVF
     KYVEQQYGQP SSKANILLGV ITIPIFASGM FLGGYIIKKF KLNTVGIAKF SCFTAVMSLS
     FYLLYFFILC ENKSVAGLTM TYDGNNPVTS HRDVPLSYCN SDCNCDESQW EPVCGNNGIT
     YISPCLAGCK SSSGNKKPIV FYNCSCLEVT GLQNRNYSAH LGECPRDDAC TRKFYFFVAI
     QVLNLFFSAL GGTSHVMLIV KIVQPELKSL ALGFHSMVIR ALGGILAPIY FGALIDTTCI
     KWSTNNCGTR GSCRTYNSTS FSRVYLGLSS MLRVSSLVLY IILIYAMKKK YQEKDINASE
     NGSVMDEANL ESLNKNKHFV PSAGADSETH C
//
